PropertyValue
?:abstract
  • Amiodarone, one of the most widely prescribed antiarrhythmic drugs to treat both ventricular and supraventricular arrhythmias, has been identified as a candidate drug for use against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We present the rationale of using amiodarone in the COVID-19 scenario, as well as whether or not amiodarone administration represents a potential strategy to prevent SARS-CoV-2 infection, rather than simply used to treat patients already symptomatic and/or with severe coronavirus disease 2019 (COVID-19), based on current evidence.
?:creator
?:doi
?:doi
  • 10.1007/s40256-020-00429-7
?:journal
  • Am_J_Cardiovasc_Drugs
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/18194ef2effbd094b3cd54276bfe0cb2f0eff8d4.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7394926.xml.json
?:pmcid
?:pmid
?:pmid
  • 32737841.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
?:type
?:year
  • 2020-08-01

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/c20i99qa>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/c20i99qa>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all